- 标题
- 摘要
- 关键词
- 实验方案
- 产品
-
Outcomes of intravitreal bevacizumab and macular photocoagulation for treatment of diabetic macular edema in a tertiary care eye hospital at Karachi
摘要： Objective: To study the outcomes of intravitreal injection of Bevacizumab and laser photocoagulation in the treatment of diabetic macular edema (DME). Methods: Seventy-two eyes of 59 patients with diabetic macular edema were divided into two groups of 41 eyes (Group-A) and 31 eyes (Group-B). Subjects in group-A were treated with three intravitreal injections of Bevacizumab (IVB), and that of group-B with macular photocoagulation. Duration of study was 9 months. Follow up pattern for both groups was 1, 2, 3 and 6 months. Best Corrected Visual acuity on log MAR (BCVA) for distance as well as near in each visitwas recorded. Retinal OCT for central macular thickness (CMT) was performed on baseline. SPSS version 20.0 was used to analyze the data. Results: Mean age of the patients was 53.76 ± 8.82 ranging to 36-71 years. Out of 59 patients, 40 (67.8%) were male and 19 (32.2%) female. It was observed that the difference of results among both groups was not significant. Fig.2 documents visual acuity recorded as Improved; Stable and Worse. Conclusion: The improvement in BCVA was significant at 6 months in both treatments. The final improvements in BCVA has been almost similar between both the treatment groups although it was noted that IVB group showed early improvement in BCVA at follow-ups of 1 and 3 months. A long term follow-up is required in these cases to see the effect of both these treatment strategies.
关键词： Diabetic Macular edema,Anti-VEGF,Central macular thickness
更新于2025-09-19 17:15:36
-
The effects of ranibizumab injections on fluorescein angiographic findings and visual acuity recovery in age-related macular degeneration
摘要： The objective of the study reported here was to evaluate the effect of ranibizumab on retinal circulation times and vessel caliber and to analyze the correlation of these factors with visual acuity (VA) prognosis in patients with age-related macular degeneration (AMD).
关键词： central macular thickness,prognosis,retinal arteriole diameter,vessel caliber,retinal vein diameter
更新于2025-09-09 09:28:46
-
Spectral domain optical coherence tomography as an adjunctive tool for screening Beh?et uveitis
摘要： Background This study investigated the association of central macular thickness (CMT) and macular volume (MV) with severity of Behc?et uveitis in the absence of macular edema (ME). Methods This retrospective, interventional study included a total 131 treatment-na?ve Behc?et patients with varying degree of uveitis in the absence of ME. The mean CMT and MV were obtained by spectral domain optical coherence tomography (SD ODT). The patients were classified according to the anatomical classification of Behc?et uveitis. The main outcome measure was comparison of mean CMT and MV with the types of Behc?et uveitis. Results Sixty patients (45.8%) with no uveitis, 41 patients (31.3%) with anterior uveitis, 18 patients (13.7%) with posterior uveitis, and 12 patients (9.2%) with panuveitis. The mean CMT were 261.6±22.2 μm in no uveitis, 268.1±17.8 μm in anterior uveitis, 306.4±32.9 μm in posterior uveitis, and 300.4±44.0 μm in panuveitis (P < 0.001). The mean MV was 8.7±0.3 mm3 in those without uveitis, 8.8±0.3 mm3 in anterior uveitis, 9.9±1.1 mm3 in those with posterior uveitis, and 9.7±0.4 mm3 in panuveitis (P < 0.001). Types of Behc?et uveitis was the only significant factor correlated with the mean CMT (B = 18.170, β = 0.408, P < 0.001) and the mean MV (B = 0.328, β = 0.652, P < 0.001). Conclusions The mean CMT and MV were significantly thicker in the Behc?et uveitis with posterior involvement. SD OCT can be used for an adjunctive tool for screening Behc?et uveitis, especially for the presence of posterior involvement.
关键词： Behc?et uveitis,macular volume,posterior involvement,spectral domain optical coherence tomography,central macular thickness
更新于2025-09-04 15:30:14